{"id":12143,"date":"2016-07-02T09:58:03","date_gmt":"2016-07-02T07:58:03","guid":{"rendered":"http:\/\/cms.stage.munich-startup.gmbh\/?p=12143"},"modified":"2017-06-14T13:56:49","modified_gmt":"2017-06-14T11:56:49","slug":"investoreninteresse-fuer-life-sciences-steigt","status":"publish","type":"post","link":"https:\/\/cms.stage.munich-startup.gmbh\/en\/12143\/investoreninteresse-fuer-life-sciences-steigt\/","title":{"rendered":"2nd Life Science Pitch Day: Investoreninteresse steigt"},"content":{"rendered":"

Der High-Tech Gr\u00fcnderfonds, die Bayer Pharma AG, die BioM Biotech Cluster Development GmbH sowie das Innovations- und Gr\u00fcnderzentrum Biotechnologie (IZB) haben im neuen Faculty Club G2B (GATEWAY TO BIOTECH) den 2nd Munich Life Science Pitch Day veranstaltet.<\/strong><\/p>\n

Zehn Gr\u00fcnderteams aus dem s\u00fcddeutschen Raum hatten die M\u00f6glichkeit, ihre innovativen Projekte vor zw\u00f6lf renommierten Venture Capital- und Pharma-Unternehmen zu pr\u00e4sentieren. Zum Investorenkreis geh\u00f6rten unter anderem Bayern Kapital, Forbion Capital Partners, LSP Venture Capital, die MIG Fonds, TVM Capital, Vesalius Biocapital, Wellington Partners sowie BayStartUP<\/a>. Alle Investoren waren begeistert von den qualitativ hochwertigen Pr\u00e4sentationen und werden die Kontakte zu den Startups aufrecht erhalten.<\/p>\n

\u201eMit dem Pitch Day m\u00f6chten wir jungen Unternehmen die Chance geben, ihr Vorhaben erfahrenen Investoren und Industrievertretern vorzustellen. Wir m\u00f6chten so zum einen die Suche nach einer geeigneten Finanzierung unterst\u00fctzen, zum anderen hoffen wir, den Gr\u00fcndern wertvolles Feedback geben zu k\u00f6nnen, wie sie ihr Konzept weiterentwickeln und ihre Strategie verbessern k\u00f6nnen\u201c,<\/p><\/blockquote>\n

so Dr. Marianne Mertens<\/strong> vom High-Tech Gr\u00fcnderfonds<\/a>.<\/p>\n

\u201eDer Pitch Day ist ein interessantes Forum, mit jungen Unternehmern und Investoren ins Gespr\u00e4ch zu kommen. Bayer ist an Partnerschaften mit jungen Life Sciences Unternehmen interessiert und hat deshalb in San Francisco und Berlin den CoLaborator etabliert. Au\u00dferdem ist Bayer als Investor beim High-Tech Gr\u00fcnderfonds engagiert\u201c,<\/p><\/blockquote>\n

so Prof. Dr. Stefan Jaroch<\/strong>, Leiter External Innovation Technologies, Bayer Pharma AG.<\/p>\n

\"Biotech_Presselounge_Investoren\"
v.l.n.r.: J\u00fcrgen Kosch, MIG Fonds; Andreas Huber, Bayern Kapital; Dr. Peter Neubeck, TVM; Barbara Dombay, Bay StartUp; John Butler-Ransohoff), Bayer Pharma AG; Dr. Matthias Kromayer, MIG AG; Dr. Karin Kleinhans, Life Science Partners; Dr. Mathias Falcenberg, Forbion Capital Partners, Petra Burgstaller, Bio M; Dr. Marianne Mertens, High Tech Gr\u00fcnderfonds, Dr. Fei Tian, Vesalius Biocapital; Dr. Stefan Jaroch, Bayer Pharma AG und Dr. Christian Jung, Wellington Partners.<\/figcaption><\/figure>\n

Fr\u00fchzeitiger Kontakt mit VCs<\/h3>\n

Mit einem B\u00fcndel an Trainings- und Beratungsangeboten werden Gr\u00fcnder in der M\u00fcnchner Region spezifisch in den Life Sciences durch die Clusterorganisation BioM<\/a> betreut. In engem Kontakt mit weiteren bayerischen Organisationen des \u201eGr\u00fcnderlandes Bayern\u201c wie BayStartUP oder auch Bayern Kapital<\/a> werden fr\u00fch alle Themen zur Unternehmensgr\u00fcndung unter anderem in Businessplan-Wettbewerben oder Coaching-Netzwerken praxisnah vermittelt. Christina Enke-Stolle<\/strong>, Senior Manager Startups & Funding von der BioM, betonte:<\/p>\n

\u201cDer Pitch-Day des HTGF passt hervorragend in unser Life Science-\u00d6kosystem in Bayern. In dem bewusst exklusiven aber auch famili\u00e4ren Setting erhalten die Gr\u00fcnder eine tolle B\u00fchne und k\u00f6nnen von dem sehr direkten Feedback auf die Pr\u00e4sentation viel mitnehmen\u201c.<\/p><\/blockquote>\n

Seit 20 Jahren profitieren die Startup-Unternehmen von dem Netzwerk an Spitzenforschern auf dem Campus Martinsried und den Dienstleistungen des IZB<\/strong><\/a>, die die IZB-Unternehmer mit den entsprechenden Multiplikatoren vernetzt. Im IZB sind derzeit \u00fcber 63 Startups und auch schon erwachsene Firmen ans\u00e4ssig.<\/p>\n

\u201eAllein in 2015 konnten sich die IZB-Unternehmen Finanzierungen in Form von Kapitalerh\u00f6hungen, Meilensteinzahlungen, Finanzierungsrunden und F\u00f6rdergeldern sowie Firmenverk\u00e4ufen von \u00fcber 660 Millionen<\/strong> auf die Fahnen schreiben\u201c,<\/p><\/blockquote>\n

freut sich Dr. Peter Zobel<\/strong>, Gesch\u00e4ftsf\u00fchrer des IZB. Bei Veranstaltungen, wie dem Pitch Day, kn\u00fcpfen angehende Unternehmer schon fr\u00fchzeitig Kontakte mit Venture Capital-Unternehmen. Und das in entspannter Atmosph\u00e4re.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Der High-Tech Gr\u00fcnderfonds, die Bayer Pharma AG, die BioM Biotech Cluster Development GmbH sowie das Innovations- und Gr\u00fcnderzentrum Biotechnologie (IZB) haben im neuen Faculty Club G2B (GATEWAY TO BIOTECH) den 2nd Munich Life Science Pitch Day veranstaltet. Zehn Gr\u00fcnderteams aus dem s\u00fcddeutschen Raum hatten die M\u00f6glichkeit, ihre innovativen Projekte vor …<\/p>","protected":false},"author":3,"featured_media":12168,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8,10,1,5131],"tags":[1012,399,155,52,1133,1499,156,74,34],"class_list":["post-12143","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-acceleratorincubator","category-investor","category-news","category-oekosystem","tag-bayern-kapital","tag-baystartup","tag-biom","tag-finanzierung","tag-htgf","tag-izb","tag-life-science","tag-pitch","tag-venture-capital"],"acf":[],"yoast_head":"\n2nd Life Science Pitch Day: Investoreninteresse steigt - Munich Startup<\/title>\n<meta name=\"description\" content=\"10 Gr\u00fcnderteams hatten beim 2nd Munich Life Science Pitch Day die M\u00f6glichkeit, ihre innovativen Projekte vor VC- und Pharma-Unternehmen zu pr\u00e4sentieren.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.stage.munich-startup.gmbh\/en\/12143\/investoreninteresse-fuer-life-sciences-steigt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2nd Life Science Pitch Day: Investoreninteresse steigt - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"10 Gr\u00fcnderteams hatten beim 2nd Munich Life Science Pitch Day die M\u00f6glichkeit, ihre innovativen Projekte vor VC- und Pharma-Unternehmen zu pr\u00e4sentieren.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.stage.munich-startup.gmbh\/en\/12143\/investoreninteresse-fuer-life-sciences-steigt\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\" \/>\n<meta property=\"article:published_time\" content=\"2016-07-02T07:58:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-06-14T11:56:49+00:00\" \/>\n<meta name=\"author\" content=\"Florian Deglmann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FlorianDeglmann\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Florian Deglmann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/\",\"url\":\"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/\",\"name\":\"2nd Life Science Pitch Day: Investoreninteresse steigt - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2016\/06\/Pitch-Day-im-IZB.jpg\",\"datePublished\":\"2016-07-02T07:58:03+00:00\",\"dateModified\":\"2017-06-14T11:56:49+00:00\",\"author\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/e9a923eaacd019b5199171badd1b772f\"},\"description\":\"10 Gr\u00fcnderteams hatten beim 2nd Munich Life Science Pitch Day die M\u00f6glichkeit, ihre innovativen Projekte vor VC- und Pharma-Unternehmen zu pr\u00e4sentieren.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#primaryimage\",\"url\":\"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2016\/06\/Pitch-Day-im-IZB.jpg\",\"contentUrl\":\"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2016\/06\/Pitch-Day-im-IZB.jpg\",\"width\":1200,\"height\":801,\"caption\":\"Andreas Huber, Bayern Kapital; Dr. Peter Zobel, Gesch\u00e4ftsf\u00fchrer Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB; Dr. Marianne Mertens, High Tech Gr\u00fcnderfonds; Dr. Stefan Jaroch, Bayer Pharma AG (v.l.n.r)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/cms.stage.munich-startup.gmbh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2nd Life Science Pitch Day: Investoreninteresse steigt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#website\",\"url\":\"https:\/\/cms.stage.munich-startup.gmbh\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.stage.munich-startup.gmbh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/e9a923eaacd019b5199171badd1b772f\",\"name\":\"Florian Deglmann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5a16a770a1cdb8f59f019287b53f6cf22c062c757827d59d6ebda81fdb697b61?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5a16a770a1cdb8f59f019287b53f6cf22c062c757827d59d6ebda81fdb697b61?s=96&d=mm&r=g\",\"caption\":\"Florian Deglmann\"},\"description\":\"Der Exil-N\u00fcrnberger erforschte bis April 2019 als Redakteur die M\u00fcnchner Startup-Szene.\",\"sameAs\":[\"http:\/\/cms.stage.munich-startup.gmbh\",\"https:\/\/www.facebook.com\/profile.php?id=100009572160192\",\"https:\/\/x.com\/FlorianDeglmann\"],\"url\":\"https:\/\/cms.stage.munich-startup.gmbh\/en\/author\/deglmann\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-content\/uploads\/2016\/06\/Pitch-Day-im-IZB.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"801\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2nd Life Science Pitch Day: Investoreninteresse steigt - Munich Startup","description":"10 Gr\u00fcnderteams hatten beim 2nd Munich Life Science Pitch Day die M\u00f6glichkeit, ihre innovativen Projekte vor VC- und Pharma-Unternehmen zu pr\u00e4sentieren.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.stage.munich-startup.gmbh\/en\/12143\/investoreninteresse-fuer-life-sciences-steigt\/","og_locale":"en_US","og_type":"article","og_title":"2nd Life Science Pitch Day: Investoreninteresse steigt - Munich Startup","og_description":"10 Gr\u00fcnderteams hatten beim 2nd Munich Life Science Pitch Day die M\u00f6glichkeit, ihre innovativen Projekte vor VC- und Pharma-Unternehmen zu pr\u00e4sentieren.","og_url":"https:\/\/cms.stage.munich-startup.gmbh\/en\/12143\/investoreninteresse-fuer-life-sciences-steigt\/","og_site_name":"Munich Startup","article_author":"https:\/\/www.facebook.com\/profile.php?id=100009572160192","article_published_time":"2016-07-02T07:58:03+00:00","article_modified_time":"2017-06-14T11:56:49+00:00","author":"Florian Deglmann","twitter_card":"summary_large_image","twitter_creator":"@FlorianDeglmann","twitter_misc":{"Written by":"Florian Deglmann","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/","url":"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/","name":"2nd Life Science Pitch Day: Investoreninteresse steigt - Munich Startup","isPartOf":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#primaryimage"},"image":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2016\/06\/Pitch-Day-im-IZB.jpg","datePublished":"2016-07-02T07:58:03+00:00","dateModified":"2017-06-14T11:56:49+00:00","author":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/e9a923eaacd019b5199171badd1b772f"},"description":"10 Gr\u00fcnderteams hatten beim 2nd Munich Life Science Pitch Day die M\u00f6glichkeit, ihre innovativen Projekte vor VC- und Pharma-Unternehmen zu pr\u00e4sentieren.","breadcrumb":{"@id":"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#primaryimage","url":"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2016\/06\/Pitch-Day-im-IZB.jpg","contentUrl":"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2016\/06\/Pitch-Day-im-IZB.jpg","width":1200,"height":801,"caption":"Andreas Huber, Bayern Kapital; Dr. Peter Zobel, Gesch\u00e4ftsf\u00fchrer Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB; Dr. Marianne Mertens, High Tech Gr\u00fcnderfonds; Dr. Stefan Jaroch, Bayer Pharma AG (v.l.n.r)"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.stage.munich-startup.gmbh\/12143\/investoreninteresse-fuer-life-sciences-steigt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/cms.stage.munich-startup.gmbh\/"},{"@type":"ListItem","position":2,"name":"2nd Life Science Pitch Day: Investoreninteresse steigt"}]},{"@type":"WebSite","@id":"https:\/\/cms.stage.munich-startup.gmbh\/#website","url":"https:\/\/cms.stage.munich-startup.gmbh\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.stage.munich-startup.gmbh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/e9a923eaacd019b5199171badd1b772f","name":"Florian Deglmann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.stage.munich-startup.gmbh\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5a16a770a1cdb8f59f019287b53f6cf22c062c757827d59d6ebda81fdb697b61?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5a16a770a1cdb8f59f019287b53f6cf22c062c757827d59d6ebda81fdb697b61?s=96&d=mm&r=g","caption":"Florian Deglmann"},"description":"Der Exil-N\u00fcrnberger erforschte bis April 2019 als Redakteur die M\u00fcnchner Startup-Szene.","sameAs":["http:\/\/cms.stage.munich-startup.gmbh","https:\/\/www.facebook.com\/profile.php?id=100009572160192","https:\/\/x.com\/FlorianDeglmann"],"url":"https:\/\/cms.stage.munich-startup.gmbh\/en\/author\/deglmann\/"}]},"og_image":[{"width":1200,"height":801,"url":"https:\/\/cms.stage.munich-startup.gmbh\/wp-content\/uploads\/2016\/06\/Pitch-Day-im-IZB.jpg","type":"image\/jpeg"}]},"_links":{"self":[{"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/posts\/12143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/comments?post=12143"}],"version-history":[{"count":0,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/posts\/12143\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/media\/12168"}],"wp:attachment":[{"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/media?parent=12143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/categories?post=12143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.stage.munich-startup.gmbh\/en\/wp-json\/wp\/v2\/tags?post=12143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}